“COMPARISON OF THE EFFECT OF SILDENAFIL AND TADALAFIL ON PULMONARY HYPERTENSION ASSOCIATED WITH HEMODYNAMICALLY SIGNIFICANT PDAS TREATMENT OF PULMONARY HYPERTENSION IN HS-PDA PATIENTS”. 2022. Journal of Pharmaceutical Negative Results, December, 3266-74. https://www.pnrjournal.com/index.php/home/article/view/4563.